Blood Test Spots Who Benefits From Drug
The anti-cancer drug erlotinib ( Tarceva ) may slow or stop cancer depending on the type and extent of the disease. A blood test can help patients find out how they will respond to the drug.
A Welcome Skin Rash
For most people, getting a rash would not be good news. For elderly patients with advanced non-small cell lung cancer, however, a rash may indicate a likelihood of living longer.
Want To Live 10 Years Longer?
It’s no secret that smoking is bad for a person’s health. But what are the real risks? Keep reading for the exact odds of smoking-related health problems in over a million women.
Diesel Fuels Lung Cancer Risk
Those who live near highways, truck drivers and others who breathe in diesel fumes may be more likely to get lung cancer. A large study of trucking industry workers has recently found that cumulative exposure to diesel exhaust increases the likelihood of dying from lung cancer.
Blood Test May Sound Early Cancer Alarm
Finding lung cancer early can save a life. Screening options, however, are costly, invasive or both. An altered protein, found in the blood, may be key to a simpler, more affordable option.
In the Cancer Game Quitters Are Winners
Why bother quitting smoking if you already have lung cancer? A recent report claims that patients can benefit from stopping even in the later stages of the disease.
Realistic Expectations Are a Good Thing
Hope is an important part of fighting cancer. But unrealistic optimism in the final stages of cancer can influence important patient decisions.
When Cancer Drug Trials Are Flawed
Chemotherapy drugs like docetaxel stop or slow cancer cell growth. Adding another medication to the chemo that blocks blood vessel growth may help patients live longer.
Potential Therapy Aims for Cancer Bull's-Eye
Research has found that cell enzymes are key to controlling the spread of lung cancer. Now scientists have pinpointed an enzyme that responds to drug treatment, killing cancer cells.
Many Not Getting Life-Prolonging Therapy
Radiation treatment is effective at shrinking tumors and killing cancer cells. While this type of treatment can extend lives, many lung cancer patients are not receiving the therapy. But why?